Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Combinations of Long-acting β2-agonists (LABA) and Inhaled Glucocorticosteroid (ICS)
Clinical trial NCT01329029 · COMPLETED
Trial details
- NCT number
- NCT01329029
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2014-03-01
- Enrollment
- 1945
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.